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The Effects of Dapiprazole on the Reversal of 5% 
Phenylephrine/0.5% Tropicamide Induced Mydriasis 
Introduction 
Pupillary dilation to allow fundus examination is an integral 
part of the comprehensive vision exam. Binocular Indirect 
Ophthalmoscopy (BIO) and high plus ophthalmoscopy allow a more 
comprehensive assessment of the posterior pole and peripheral 
fundus. Because of the increased illumination necessary to perform 
the previously mentioned techniques, diagnostic pharmaceutical 
agents are needed to provide and maintain adequate pupil size. The 
standard protocol involves the instillation of two consecutive drops 
at 5 minute intervals. Typically, these drops include one each of 
phenylephrine 2.5% and tropicamide 1.0%. Phenylephrine, a 
sympathomimetic, contracts the iris dilator muscle and tropicamide, 
a parasympatholytic, relaxes the iris sphincter muscle. The 
combined effects of these agents inhibit the efferent pupillary light 
reflex. Many practitioners and patients find this pupillary dilation 
process both time consuming and bothersome. A previous attempt to 
resolve this problem was made with the introduction of the 
combination mydriatic solution Paremyd which contains 1.0% 
hydroxyamphetamine and .25% tropicamide. However, there is a 
general feeling among clinicians that Paremyd does not provide an 
adequate maximum pupillary dilation. 
It has been proposed that a mydriatic solution containing a 
combination of 5% phenylephrine and 0.5% tropicamide would 
reduce the time and inconvenience of the standard protocol by 
lowering the number of consecutive drops from two to one and at the 
same time achieve a satisfactory maximum pupillary dilation. 
Studies have already been conducted as to the onset, peak, and 
duration of dilation of this mydriatic solution. The purpose of this 
study is to evaluate the efficacy of dapiprazole (Rev-Eyes™), an a-
adrenergic antagonist, in the reversal of mydriasis induced with this 
proposed solution. 
The reversal effects of a-adrenergic antagonists of mydriasis 
caused by the standard dilating agents Tropicamide 1% and 
phenylephrine 2.5% is well documented. This reversal is typically 
complete in approximately one hour. In this study, the efficacy of 
dapiprazole HCl 0.5% (Rev-Eyes™) in reversing the mydriasis induced 
by 5% phenylephrine and 0.5% tropicamide was compared to the 
efficacy of Rev-Eyes™ in reversing the mydriasis induced by the 
standard 1% tropicamide and 2.5% phenylephrine. 
Dapiprazole HCl is an a-adrenergic antagonist that produced 
miosis and slightly reduces lOP following instillation in the eye. 
Dapiprazole exerts its action on the a-receptors of the iris dilator 
muscle. Through competitive inhibition, it occupies these receptors and 
prevents their further stimulation by a-receptors agonists such as 
phenylepherine. 
Relative to the number of drops each patient received and the 
concentrations of drug contained in each drop, we hypothesize that 
Rev-Eyes™ will reverse the mydriasis caused by 5% phenylephrine 
and 0.5% tropicamide at least as fast as the mydriasis caused by the 
standard tropicamide 1% and phenylephrine 2.5%. 
Materials and Methods 
This study involved the use of ten subjects, all students at PUCO. 
Each were evaluated prior to the study using the Von Herrick method 
of angle estimation to ensure open angles. This method was used to 
evaluate the nasal and temporal angles in each subject to reduce the 
likelihood of angle closure. Goldmann Applanation Tonometry was 
performed one day prior to the experiment. Pressures were taken to 
ensure lOP was within normal limits and to reduce the possibility of 
the anesthetic altering the absorption of the mydriatic drops. 
Iris color was noted prior to the study as well. Blood pressure was 
taken prior to the study to ensure all the subjects were within normal 
limits for their respective age groups. 
Pre-requisites for participation in the study included no ocular 
pathology and best corrected visual acuity of 20/20 OU or better. 
The study performed was double blind -- neither the experimenters or 
the subjects knew which drops were being used on any of the subjects. 
The study was performed on two consecutive Saturdays 
The initial Saturday one half the test group received the standard 
dilating agents and the other half received one drop of the 
experimental solution. Baseline pupil diameters were measured prior 
to instillation of the drops. Pupil diameters were measured until 
maximum dilation was achieved. At that time, Rev-Eyes™ was 
instilled as in a manner consistent with the package insert (two drops 
in each eye, followed by two more drops five minutes later). At that 
point pupil diameter was measured every five minutes for 30 minutes 
for a total of 6 measurements, then every 15 minutes for one hour ( 4 
times) then every half hour for one hour (2 times) 
Measurements were taken with the Shinn-Nippon digital PD-82 
Pupillometer. Inter-examiner variability was avoided in all 
measurements by having the same examiner take measurements on all 
subjects. Pupils were measured with the pupillometer to the nearest 
0.5mm in the horizontal meridian. This was done by setting the 
pupillometer to the infinity setting. Monocular horizontal pupil 
measurements were taken by aligning the vernier with the temporal 
edge of the pupil, obtaining a reading, aligning the vernier with the 
nasal edge of the pupil and obtaining another reading. The difference 
between the two readings was the pupil diameter. The procedure was 
then repeated for the other eye. The following Saturday, the opposite 
drop was given to each subject and the measurements were repeated 
in the same manner. 
Results 
After the data was collected, it was then analyzed using the 
statistical hog-wash to allow us to compare and contrast the reversal 
characteristics relative to each mydriatic drop. Is it at least as 
effective??? 
